Insights

Healthcare Innovation AKASA's deployment of GenAI solutions in healthcare finance, particularly its comprehensive work with leading health systems like Cleveland Clinic, demonstrates its ability to modernize revenue cycle workflows and improve financial outcomes. This positions AKASA as an ideal partner for large hospital networks seeking AI-driven revenue enhancement.

Revenue Impact With an average of 3.1 million dollars in additional revenue per customer and enhancements across key quality indicators, AKASA offers measurable financial benefits that can be a compelling selling point for health systems aiming to boost revenue and operational efficiency.

Product Expansion Recent launches such as AKASA CDI Optimizer, Medical Coding, and Authorization Advisor illustrate a strategic focus on expanding its AI-assisted tools to cover various critical aspects of healthcare revenue cycle management, creating multiple upsell or cross-sell opportunities.

Investment & Growth Backed by notable investors including Andreessen Horowitz, AKASA has raised over $200 million, highlighting strong financial support and growth potential. This positions the company for further scaling and innovation, appealing to health systems seeking trusted, cutting-edge AI solutions.

Market Positioning AKASA’s focus on delivering tailored LLMs for each health system to capture clinical nuances strikes a competitive advantage, offering clients highly accurate and customized AI tools. This differentiates AKASA as a premium solution provider in the healthcare AI market, ideal for large, complex health organizations.

AKASA Tech Stack

AKASA uses 8 technology products and services including OpenSearch, OAuth, Asana, and more. Explore AKASA's tech stack below.

  • OpenSearch
    Analytics
  • OAuth
    Identity And Access Management
  • Asana
    Issue Trackers
  • SEMrush
    Marketing Automation
  • Go
    Programming Languages
  • Node.js
    Programming Languages
  • Ahrefs
    Search Marketing
  • Facebook
    Widgets

Media & News

AKASA's Email Address Formats

AKASA uses at least 1 format(s):
AKASA Email FormatsExamplePercentage
First.Last@akasa.comJohn.Doe@akasa.com
93%
First@akasa.comJohn@akasa.com
4%
FLast@akasa.comJDoe@akasa.com
2%
Last@akasa.comDoe@akasa.com
1%

Frequently Asked Questions

Where is AKASA's headquarters located?

Minus sign iconPlus sign icon
AKASA's main headquarters is located at South San Francisco, California United States. The company has employees across 5 continents, including North AmericaAsiaAfrica.

What is AKASA's stock symbol?

Minus sign iconPlus sign icon
AKASA is a publicly traded company; the company's stock symbol is 6022.T.

What is AKASA's official website and social media links?

Minus sign iconPlus sign icon
AKASA's official website is akasa.com and has social profiles on LinkedInCrunchbase.

What is AKASA's NAICS code?

Minus sign iconPlus sign icon
AKASA's NAICS code is 5112 - Software Publishers.

How many employees does AKASA have currently?

Minus sign iconPlus sign icon
As of April 2026, AKASA has approximately 223 employees across 5 continents, including North AmericaAsiaAfrica. Key team members include Chief Product Officer: C. C.Head Of Commercial Growth: R. T.Head Of Cloud Infrastructure: N. R.. Explore AKASA's employee directory with LeadIQ.

What industry does AKASA belong to?

Minus sign iconPlus sign icon
AKASA operates in the Software Development industry.

What technology does AKASA use?

Minus sign iconPlus sign icon
AKASA's tech stack includes OpenSearchOAuthAsanaSEMrushGoNode.jsAhrefsFacebook.

What is AKASA's email format?

Minus sign iconPlus sign icon
AKASA's email format typically follows the pattern of First.Last@akasa.com. Find more AKASA email formats with LeadIQ.

When was AKASA founded?

Minus sign iconPlus sign icon
AKASA was founded in 2019.

AKASA

Software DevelopmentCalifornia, United States201-500 Employees

AKASA is rapidly becoming the GenAI partner of choice for leading health systems, with recent national recognition of our Cleveland Clinic deployment as “one of the most comprehensive real-world uses of GenAI in healthcare finance to date.” 

Across customers, AKASA now delivers an average of $3.1M in additional revenue and 4,270 additional quality indicators per 10,000 discharges, demonstrating consistent, measurable impact.

Our advantage comes from building a custom LLM for each health system, capturing their clinical nuance to drive superior accuracy across the mid-cycle — spanning prior authorization, CDI, inpatient coding, and clinical denials appeals. This approach allows organizations to modernize critical workflows and unlock material improvements in both revenue and quality.

With investors including Andreessen Horowitz, BOND, Costanoa Ventures, and others, we’ve raised more than $200M to help eliminate the financial complexity of healthcare.

We’re rebuilding the revenue cycle with AI. Let’s chat.

Section iconCompany Overview

Headquarters
South San Francisco, California United States
Website
akasa.com
Stock Symbol
6022.T
NAICS Code
5112 - Software Publishers
Founded
2019
Employees
201-500

Section iconFunding & Financials

  • $100M$250M

    AKASA's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $100M$250M

    AKASA's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.